Transgenic plants are showing considerable potential for the economic production of proteins, with a few already being marketed. Recent clinical trials of pharmaceuticals produced from transgenic plants are encouraging, with plant glycans showing reassuringly poor immunogenicity. Our increasing understanding of protein targeting and accumulation should further improve the potential of this new technology
Imagine a world in which any protein, either naturally occurring or designed by man, could be produc...
Molecular farming is the production of pharmaceutically important and commercially valuable proteins...
Many different plant-based systems have been used to produce recombinant pharmaceutical proteins but...
Transgenic plants are showing considerable potential for the economic production of proteins, with a...
Many of our 'small-molecule-drugs' are natural products from plants, or are synthetic compounds base...
Recent advances in molecular and cellular biology have led to the development of technology to engin...
Plants have considerable potential for the production of biopharmaceutical proteins and peptides bec...
Plants have considerable potential for the production of biopharmaceutical proteins and peptides bec...
274-290Recent advances in molecular and cellular biology have led to the development of technology t...
Future farms will produce food more efficiently, perhaps in environments where originally it was con...
Plants are particularly attractive as large-scale production systems for proteins intended for thera...
Plants are particularly attractive as large-scale production systems for proteins intended for thera...
The first recombinant plant‐derived pharmaceutical protein (PDP) was human serum albumin, initially ...
The use of plants as a new platform for the large-scale production of biopharmaceutical proteins is ...
Plants are now gaining widespread acceptance as a general platform for the large-scale production of...
Imagine a world in which any protein, either naturally occurring or designed by man, could be produc...
Molecular farming is the production of pharmaceutically important and commercially valuable proteins...
Many different plant-based systems have been used to produce recombinant pharmaceutical proteins but...
Transgenic plants are showing considerable potential for the economic production of proteins, with a...
Many of our 'small-molecule-drugs' are natural products from plants, or are synthetic compounds base...
Recent advances in molecular and cellular biology have led to the development of technology to engin...
Plants have considerable potential for the production of biopharmaceutical proteins and peptides bec...
Plants have considerable potential for the production of biopharmaceutical proteins and peptides bec...
274-290Recent advances in molecular and cellular biology have led to the development of technology t...
Future farms will produce food more efficiently, perhaps in environments where originally it was con...
Plants are particularly attractive as large-scale production systems for proteins intended for thera...
Plants are particularly attractive as large-scale production systems for proteins intended for thera...
The first recombinant plant‐derived pharmaceutical protein (PDP) was human serum albumin, initially ...
The use of plants as a new platform for the large-scale production of biopharmaceutical proteins is ...
Plants are now gaining widespread acceptance as a general platform for the large-scale production of...
Imagine a world in which any protein, either naturally occurring or designed by man, could be produc...
Molecular farming is the production of pharmaceutically important and commercially valuable proteins...
Many different plant-based systems have been used to produce recombinant pharmaceutical proteins but...
DOI
Add to ORKG